Sundar Jagannath, MD, Named Director of Multiple Myeloma Program at Mount Sinai School of Medicine

Blood cancer expert Sundar Jagannath, MD, will join The Mount Sinai Medical Center as Director of the Multiple Myeloma Program.

New York, NY
 – June 1, 2010 /Press Release/  –– 

Renowned blood cancer expert Sundar Jagannath, MD, is joining The Mount Sinai Medical Center as Director of the Multiple Myeloma Program and Professor of Hematology and Medical Oncology at Mount Sinai School of Medicine’s Tisch Cancer Institute. His appointment becomes effective June 1st.

Steven J. Burakoff, MD, Director of The Tisch Cancer Institute at The Mount Sinai Medical Center, Lillian and Henry M. Stratton Professor of Cancer Medicine, and Professor of Hematology/Oncology and Oncological Sciences, said, “Dr. Jagannath is a renowned leader in multiple myeloma, and under his guidance, Tisch will have one of the biggest bone marrow transplant centers in the country.”

As Director for the Multiple Myeloma Program, Dr. Jagannath will help develop the Multiple Myeloma and Stem Cell Transplant Program into a translational and clinical research center in multiple myeloma. He will build projects that bridge basic science and clinical practices for the benefit of advancing care in blood cancer.

An internationally known researcher, Dr. Jagannath has published more than 180 peer-reviewed articles in top journals including the New England Journal of Medicine, Blood, the Journal of Clinical Oncology, the British Journal of Haematology, and Cancer. He has presented more than 150 abstracts, and authored nearly 30 book chapters. He is at the forefront of blood cancer research, and will continue his work as lead investigator on several trials while at Mount Sinai.Dr. Jagannath will also be joined by his colleague from Saint Vincent’s, Ajai Chari, MD. Dr. Chari has been named Assistant Professor of Hematology and Medical Oncology at Mount Sinai.

Dr. Jagannath has received numerous awards for his commitment to multiple myeloma research, including two Humanitarian Awards and the Spirit of Hope Award from the Multiple Myeloma Research Foundation. He is also the Honorary Chairman of “Laugh for Life,” the annual fundraiser of the foundation.

Prior to joining Mount Sinai, Dr. Jagannath was the Chief of the Multiple Myeloma Program and Bone Marrow and Stem Cell Transplantation Program at St. Vincent's Comprehensive Cancer Center (SVCCC) in New York City, where he practiced beginning in 1998. He also was a Professor of Medicine at New York Medical College.

After receiving his medical degree from Maharaja Sayajirao University, he completed his residency in internal medicine at The Bronx-Lebanon Hospital Center in the Bronx, New York and Harper-Grace Hospital in Detroit, Michigan. He was awarded a fellowship in medical oncology from MD Anderson Hospital and Tumor Institute in Houston, Texas. He continued on at MD Anderson until 1989, when he joined the University of Arkansas for Medical Sciences. He remained at the University of Arkansas as Chief of Bone Marrow Transplantation until joining SVCCC in 1998.

About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report.  The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.

The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation’s oldest, largest and most-respected voluntary hospitals.  In 2009, U.S. News & World Report ranked The Mount Sinai Hospital among the nation’s top 20 hospitals based on reputation, patient safety, and other patient-care factors.  Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.

For more information, visit